Literature DB >> 9829860

Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis.

J A del Olmo1, M A Serra, F Rodríguez, A Escudero, S Gilabert, J M Rodrigo.   

Abstract

PURPOSE: To determine the incidence of hepatocellular carcinoma in cirrhosis and to examine the influence of age and sex, and the contribution of etiological factors.
METHODS: 967 patients with liver cirrhosis and free of hepatocellular carcinoma were enrolled in this longitudinal, retrospective and observational study. Monitoring for hepatocellular carcinoma was scheduled at 3- to 6-month intervals. The mean (+/-SD) length of follow-up was 60.3+/-51.7 months (range 6 258).
RESULTS: During the observation period, hepatocellular carcinoma developed in 64 patients. The calculated annual incidence was 2.1%. The probability of being free of liver cancer was 92% at 5 years, 80% at 10 years, and 69% at 15 years. Age was the only independent risk factor for the development of malignancy in the multivariate analysis. There were no differences according to male sex, alcohol abuse, and chronic hepatitis B and C virus infection.
CONCLUSIONS: The annual incidence of hepatocellular carcinoma was 2.1%. These results, although confirming that age is a risk factor for hepatocellular carcinoma in cirrhosis, indicate that alcohol abuse, male sex, and concurrent hepatitis B and C virus infection do not involve a higher risk of developing liver cancer.

Entities:  

Mesh:

Year:  1998        PMID: 9829860     DOI: 10.1007/s004320050215

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  6 in total

1.  A mouse model of accelerated liver aging caused by a defect in DNA repair.

Authors:  Siobhán Q Gregg; Verónica Gutiérrez; Andria Rasile Robinson; Tyler Woodell; Atsunori Nakao; Mark A Ross; George K Michalopoulos; Lora Rigatti; Carrie E Rothermel; Irene Kamileri; George A Garinis; Donna Beer Stolz; Laura J Niedernhofer
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

2.  Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study.

Authors:  Pin-Gao Yan; Ruo-Yu Wang; Jin Zhang; Wen-Ming Cong; Hui Dong; Hong-Yu Yu; Wan Yee Lau; Meng-Chao Wu; Wei-Ping Zhou
Journal:  J Gastrointest Surg       Date:  2018-01-08       Impact factor: 3.452

3.  Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.

Authors:  C Rabe; T Pilz; C Klostermann; M Berna; H H Schild; T Sauerbruch; W H Caselmann
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 4.  Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues.

Authors:  Irene Rapti; Stephanos Hadziyannis
Journal:  World J Hepatol       Date:  2015-05-18

5.  Does an association exist between chronic pancreatitis and liver cirrhosis in alcoholic subjects?

Authors:  Luis Aparisi; Luis Sabater; Juan Del-Olmo; Juan Sastre; Miguel-Angel Serra; Ricardo Campello; Daniel Bautista; Abdalla Wassel; Jose-Manuel Rodrigo
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

6.  Alpha-actinin 4 and tumorigenesis of hepatocellular carcinoma.

Authors:  Guidong Wang; Yuhua Li; Bin Tang; Qing Yu
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.